Barbeau G R, Seeger J M, Jablonski S, Kaelin L D, Friedl S E, Abela G S
Department of Medicine, Laval University, Quebec, Canada.
Clin Cardiol. 1996 Mar;19(3):232-8. doi: 10.1002/clc.4960190318.
The treatment of patients with complex peripheral arterial disease and those who have had previous unsuccessful attempted revascularization procedures can be clinically challenging. Initial treatment was begun using therapy by percutaneous balloon and laser angioplasty, then proceeding to bypass surgery if severe ischemia persisted. Both percutaneous and cut-down approaches were used to access totally occluded arteries. An attempt was made to cross the occlusion mechanically with either a guide wire or an activated laser probe. If laser recanalization was not successful, the patient underwent bypass surgery or was managed with medication unless an amputation was necessary. Following initial screening of 381 patients, 115 procedures were performed on 103 patients. In 31 procedures (28 patients), only balloon angioplasty was performed. In 84 procedures (75 patients), laser recanalization was attempted: 55 percutaneously and 29 by cut-down. Overall technical success (crossing the obstruction without perforation) was 86/115 (75%). Technically successful procedures were characterized by shorter arterial occlusions than were technical failures (8.4 +/- 1 cm vs. 14.3 +/- 1.9 cm; p < 0.004). Clinical success (residual stenosis < 50%, symptom relief, improved ankle brachial index > or = 0.15, and no complications) was achieved in 22/31 (71%) of balloon angioplasty procedures alone. The stenoses decreased from 98 +/- 4% to 31 +/- 24%, p < 0.00001. Combined percutaneous laser and balloon angioplasty had a technical success of 36/55 (65%). Stenoses were reduced from 99 +/- 2% to 56 +/- 14% after laser angioplasty, to 30 +/- 15% after balloon angioplasty, p < 0.0001. Laser angioplasty performed via a cut-down had a clinical success of 9/29 (31%). However, major complications were rare. Device staging for treatment of peripheral vascular disease provides additional options for patients who are at high surgical risk and/or in whom standard therapy has failed.
治疗患有复杂外周动脉疾病的患者以及那些先前血管重建手术尝试失败的患者在临床上具有挑战性。初始治疗开始时采用经皮球囊和激光血管成形术,若严重缺血持续存在则接着进行搭桥手术。经皮和切开入路均被用于进入完全闭塞的动脉。尝试使用导丝或激活的激光探头机械穿过闭塞段。如果激光再通不成功,患者接受搭桥手术或药物治疗,除非有必要进行截肢。在对381例患者进行初步筛查后,对103例患者实施了115例手术。在31例手术(28例患者)中,仅进行了球囊血管成形术。在84例手术(75例患者)中,尝试进行激光再通:55例经皮进行,29例通过切开进行。总体技术成功率(穿过阻塞且无穿孔)为86/115(75%)。技术成功的手术其动脉闭塞长度比技术失败的手术短(8.4±1厘米对14.3±1.9厘米;p<0.004)。仅球囊血管成形术的22/31(71%)例手术取得了临床成功(残余狭窄<50%、症状缓解、踝肱指数改善≥0.15且无并发症)。狭窄率从98±4%降至31±24%,p<0.00001。经皮激光和球囊血管成形术联合应用的技术成功率为36/55(65%)。激光血管成形术后狭窄率从99±2%降至56±14%,球囊血管成形术后降至30±15%,p<0.0001。通过切开进行的激光血管成形术临床成功率为9/29(31%)。然而,主要并发症很少见。用于外周血管疾病治疗的器械分期为手术风险高和/或标准治疗失败的患者提供了更多选择。